![Ibex uses AI to help pathologists minimize diagnostic errors. Photo: Courtesy Ibex Medical Analytics](https://nocamels.com/wp-content/uploads/2020/06/Ibex-Medical-Analytics-350x197.jpg)
AI Cancer Diagnostics Firm Ibex Granted FDA Breakthrough Device Designation
The designation is for the Ibex Galen platform, a solution that helps pathologists detect and grade cancer in biopsies.
June 09, 2021
![Israeli-born professor Regina Barzilay of MIT’s Computer Science and Artificial Intelligence Laboratory won a $1 million award by the Association for the Advancement of Artificial Intelligence (AAAI) for her work using AI to diagnose cancer and develop antibiotics. Photo: MIT CSAIL](https://nocamels.com/wp-content/uploads/2020/09/Regina-Barzilay-headshot-photo-credit-MIT-CSAIL-e1600715724473-350x202.jpg)
Israeli MIT Professor Wins $1M Prize For AI Work In Cancer Diagnostics, Drug Development
Professor Regina Barzilay is being honored for her work using ML models to detect and predict cancer, and accelerate drug development.
September 23, 2020
![A heatmap view of a previously-missed prostate cancer detected by Ibex's Galen Prostate platform. Courtesy](https://nocamels.com/wp-content/uploads/2020/07/Ibexprostate-350x197.jpg)
Israeli AI Diagnostics Firm Ibex Detects Cancer Using Advanced Algorithms
Ibex Medical Analytics' AI-powered technology helps pathologists detect and grade cancer in biopsies.
July 30, 2020
![Ibex uses AI to help pathologists minimize diagnostic errors. Photo: Courtesy Ibex Medical Analytics](https://nocamels.com/wp-content/uploads/2020/06/Ibex-Medical-Analytics-350x197.jpg)
Israeli AI Diagnostics Firm Ibex To Roll Out Cancer Screening For NHS Patients In UK
Founded in 2014, Ibex develops clinical-grade, AI-based solutions that help pathologists detect and grade cancer in biopsies
June 30, 2020